Ethanolamine hydrochloride

CAS No. 2002-24-6

Ethanolamine hydrochloride ( 2-Aminoethanol hydrochloride )

Catalog No. M27552 CAS No. 2002-24-6

Ethanolamine, a viscous, hygroscopic amino alcohol with an ammoniacal odor, is widely distributed in biological tissue and is a component of lecithin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 26 In Stock

Biological Information

  • Product Name
    Ethanolamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethanolamine, a viscous, hygroscopic amino alcohol with an ammoniacal odor, is widely distributed in biological tissue and is a component of lecithin.
  • Description
    Ethanolamine, a viscous, hygroscopic amino alcohol with an ammoniacal odor, is widely distributed in biological tissue and is a component of lecithin.
  • Synonyms
    2-Aminoethanol hydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Nurr1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2002-24-6
  • Formula Weight
    97.5
  • Molecular Formula
    C2H8ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.NCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Montarolo F, et al. Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. PLoS One. 2014 Sep 29;9(9):e108791.
molnova catalog
related products
  • Thalidomide 4'-ether...

    Thalidomide 4'-ether-alkylC2-amine hydrochloride is a synthesized E3 ligase ligand-linker conjugate.

  • 1R,3S-RSL 3

    1R,3S-RSL 3 is a harmala alkaloid.

  • MAGE-A3 195-203

    This peptide MAGE-3-encoded HLA-A24 epitope is a high MHC binder.The identification of this MAGE-3/HLA-A24 peptide may as a result effectiveially offer the opportunities to design peptide-based immunotherapeutic approaches that might prove to be potent in treating patients with MAGE-3-positive malignant tumors.